Skip to content
Catalyst

metforminPapers

Papers about metformin

papers
3,984
41 years, by papers

Newest first

2,901 to 2,950 of 3,984

Every paper here, unless its row says otherwiseIndexed under metformin in PubMed's chemical list; returned by a PubMed search for metformin

  • Determinants of maternal triglycerides in women with gestational diabetes mellitus in the Metformin in Gestational Diabetes (MiG) study.

    Diabetes care2013PMID 23393209

  • A Phase IIb, randomized, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes.

    Diabetes, obesity & metabolism2013PMID 23398530Indexed under metformin in PubMed's chemical list

  • Vitamin B12 and homocysteine status during pregnancy in the metformin in gestational diabetes trial: responses to maternal metformin compared with insulin treatment.

    Diabetes, obesity & metabolism2013PMID 23402546

  • A comparison between sitagliptin or glibenclamide in addition to metformin + pioglitazone on glycaemic control and β-cell function: the triple oral therapy.

    Diabetic medicine2013PMID 23413771

  • Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.

    Metabolism: clinical and experimental2013PMID 23419783

  • Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes.

    Diabetes, obesity & metabolism2013PMID 23421331

  • Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial.

    BMC medicine2013PMID 23425012Indexed under metformin in PubMed's chemical list

  • A randomized, double-blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetes patients already treated with pioglitazone and metformin: a 3-year study.

    Diabetes technology & therapeutics2013PMID 23427864

  • Effect of metformin on ovulation and reproductive outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.

    Archives of gynecology and obstetrics2013PMID 23430028

  • Effects of insulin glargine versus metformin on glycemic variability, microvascular and beta-cell function in early type 2 diabetes.

    Acta diabetologica2013PMID 23430192

  • Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review.

    European review for medical and pharmacological sciences2013PMID 23436666

  • Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes.

    Drug design, development and therapy2013PMID 23439744Indexed under metformin in PubMed's chemical list

  • Effects of low-dose metformin and rosiglitazone on biochemical, clinical, metabolic and biophysical outcomes in polycystic ovary syndrome.

    Journal of obstetrics and gynaecology2013PMID 23445141

  • Serum free fatty acid levels in PCOS patients treated with glucophage, magnesium oxide and spironolactone.

    Gynecological endocrinology2013PMID 23461841Indexed under metformin in PubMed's chemical list

  • Dose-ranging study with the glucokinase activator AZD1656 in patients with type 2 diabetes mellitus on metformin.

    Diabetes, obesity & metabolism2013PMID 23464532

  • Glimepiride strongly enhances the glucose-lowering effect in triple oral antidiabetes therapy with sitagliptin and metformin for Japanese patients with type 2 diabetes mellitus.

    Diabetes technology & therapeutics2013PMID 23480592

  • Free fatty acid binding protein-4 and retinol binding protein-4 in polycystic ovary syndrome: response to simvastatin and metformin therapies.

    Gynecological endocrinology2013PMID 23480783Indexed under metformin in PubMed's chemical list

  • Metformin modifies the exercise training effects on risk factors for cardiovascular disease in impaired glucose tolerant adults.

    Obesity (Silver Spring, Md.)2013PMID 23505172

  • Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients.

    Circulation. Heart failure2013PMID 23508758

  • Pioglitazone Randomised Italian Study on Metabolic Syndrome (PRISMA): effect of pioglitazone with metformin on HDL-C levels in Type 2 diabetic patients.

    Journal of endocrinological investigation2013PMID 23511244

  • Randomized trial of metformin vs insulin in the management of gestational diabetes.

    American journal of obstetrics and gynecology2013PMID 23524173

  • Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin.

    European journal of gastroenterology & hepatology2013PMID 23524525Indexed under metformin in PubMed's chemical list

  • Efficacy and safety of lixisenatide once-daily morning or evening injections in type 2 diabetes inadequately controlled on metformin (GetGoal-M).

    Diabetes care2013PMID 23536584

  • Sitagliptin pretreatment in diabetes patients presenting with acute coronary syndrome: results from the Acute Coronary Syndrome Israeli Survey (ACSIS).

    Cardiovascular diabetology2013PMID 23537430Indexed under metformin in PubMed's chemical list

  • Bioequivalence of saxagliptin/metformin immediate release (IR) fixed-dose combination tablets and single-component saxagliptin and metformin IR tablets in healthy adult subjects.

    Clinical drug investigation2013PMID 23549864

  • Effect of metformin on selected parameters of hemostasis in fenofibrate-treated patients with impaired glucose tolerance.

    Pharmacological reports2013PMID 23563040

  • Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial.

    Diabetes care2013PMID 23564919

  • Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus - results from an exploratory study.

    Cardiovascular diabetology2013PMID 23565740

  • The effect of high-dose insulin analog initiation therapy on lipid peroxidation products and oxidative stress markers in type 2 diabetic patients.

    Oxidative medicine and cellular longevity2013PMID 23577222

  • Mechanisms of glucose lowering of dipeptidyl peptidase-4 inhibitor sitagliptin when used alone or with metformin in type 2 diabetes: a double-tracer study.

    Diabetes care2013PMID 23579178

  • The efficacy of metformin in pregnant women with polycystic ovary syndrome: a meta-analysis of clinical trials.

    Journal of endocrinological investigation2013PMID 23580001

  • Efficacy and safety over 26 weeks of an oral treatment strategy including sitagliptin compared with an injectable treatment strategy with liraglutide in patients with type 2 diabetes mellitus inadequately controlled on metformin: a randomised clinical trial.

    Diabetologia2013PMID 23604551

  • Metformin treatment in different phenotypes of polycystic ovary syndrome.

    Archives of gynecology and obstetrics2013PMID 23605170

  • RETRACTED: Evaluation of the positive effects on insulin-resistance and β-cell measurements of vildagliptin in addition to metformin in type 2 diabetic patients.

    Pharmacological research2013PMID 23624419

  • Study design and rationale of a dose-ranging trial of LX4211, a dual inhibitor of SGLT1 and SGLT2, in type 2 diabetes inadequately controlled on metformin monotherapy.

    Clinical cardiology2013PMID 23630033

  • Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus.

    BMC pharmacology & toxicology2013PMID 23631443

  • Saxagliptin vs. glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: long-term (52-week) extension of a 52-week randomised controlled trial.

    International journal of clinical practice2013PMID 23638466

  • Randomized trial of continuous subcutaneous delivery of exenatide by ITCA 650 versus twice-daily exenatide injections in metformin-treated type 2 diabetes.

    Diabetes care2013PMID 23645886

  • The effects of sulfonylureas plus metformin on lipids, blood pressure, and adverse events in type 2 diabetes: a meta-analysis of randomized controlled trials.

    Endocrine2013PMID 23657947

  • Maternal metformin treatment decreases fetal inflammation in a rat model of obesity and metabolic syndrome.

    American journal of obstetrics and gynecology2013PMID 23659985

  • Efficacy and safety of linagliptin added to metformin and sulphonylurea in Chinese patients with type 2 diabetes: a sub-analysis of data from a randomised clinical trial.

    Current medical research and opinion2013PMID 23672632

  • Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial.

    Reproductive sciences (Thousand Oaks, Calif.)2013PMID 23690338

  • Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X).

    Diabetes care2013PMID 23698396

  • Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY.

    Diabetes care2013PMID 23704674

  • Metformin vs insulin in the management of gestational diabetes: a meta-analysis.

    PloS one2013PMID 23724063

  • Lymphocyte-suppressing, endothelial-protective and systemic anti-inflammatory effects of metformin in fenofibrate-treated patients with impaired glucose tolerance.

    Pharmacological reports2013PMID 23744427

  • Variation in inflammatory markers and glycemic parameters after 12 months of exenatide plus metformin treatment compared with metformin alone: a randomized placebo-controlled trial.

    Pharmacotherapy2013PMID 23744726

  • One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target.

    Journal of diabetes and its complications2013PMID 23746555

  • Effects of adjunctive metformin on metabolic traits in nondiabetic clozapine-treated patients with schizophrenia and the effect of metformin discontinuation on body weight: a 24-week, randomized, double-blind, placebo-controlled study.

    The Journal of clinical psychiatry2013PMID 23759461

  • Long-term 4-year safety of saxagliptin in drug-naive and metformin-treated patients with Type 2 diabetes.

    Diabetic medicine2013PMID 23802840

The next 50 papers

← Previous 50